'M-vix' to debut in October

Published: 2007-09-06 06:59:00

Updated: 2007-09-06 06:59:00

SK Chemicals said on September 3 that the company is planning to begin selling its anti-impotence medication M-vix (mirodenafil HCl) in October as the Korea Food and Drug Administration plans to enact a bill to designate the drug as one of the controlled drugs by September 20.

The KFDA approved M-vix on July 18 as a conditional drug subject to controlled medicines.

SK Chemicals' new oral...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.